Keith Yuki Isobe

Managing Director (MD), Member of the Investment Committee Board and Head of Investment

Managing Director (MD), Member of the Investment Committee Board and Head of Investment, DG Ventures | Chief Executive Officer (CEO), ONL

 

Co-Founder of Medically and Former CFO & Member of the Board at Medcare (acquired by M3, TSE:2413)
Former President & COO at Adstars (acquired by Geniee, TSE:6562) and Former Member of the Board & COO at Geniee International Group (now Geniee)

 

Isobe carries the legacy of Yuichiro Isobe — a pioneer of Japan’s heavy chemical industry who was a founder of Kanto Denka Kogyo (TSE:4047) and former CEO of both ADEKA (TSE:4401) and Kao Corporation (TSE:4452). Grounded in this entrepreneurial heritage, he studied business administration, earning an MBA from Waseda University.

 

Isobe brings more than 20 years of experience across entrepreneurship, corporate management, and venture capital. Prior to DG, he worked in international consulting at a leading global professional-services firm before co-founding Medically (exited to M3), serving as Board Member & CFO of Medcare, President & COO of Adstars, and Board Member & COO of Geniee International Group, in addition to a founder of advisory firms specializing for startup M&A, secondaries, and private equity.

 

At DG Ventures (AUM 500M+, 200+ direct investments, +40 fund-of-funds LP commitments), Isobe leads investment activities as Managing Director and Investment Committee Member, while concurrently serving as CEO of ONL. His portfolio includes multiple unicorns — such as GrubMarket ($4.5B valuation), Mysten Labs ($2B+), Playco ($1B), Lime (now NASDAQ: LIME), NoBroker, Healthians, MX, and Quantstamp — alongside +10 exits and IPOs.


Back